XML 65 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Pre-Tax Compensation Expense and the Related Income Tax Benefit for these Stock-Based Incentives
Pre-tax compensation expense included in income before income taxes for these stock-based incentives was as follows, in millions:
Year Ended December 31,
 202420232022
Restricted stock units$26 $15 $32 
Performance restricted stock units
Stock options
Long-term stock awards— 
Phantom stock awards and stock appreciation rights
Total$39 $31 $49 
Schedule of the Company's Long-Term Stock Award Activity
Our restricted stock unit activity was as follows, units in thousands:
Year Ended December 31,
202420232022
 Number of SharesWeighted Average Grant Date Fair ValueNumber of SharesWeighted Average Grant Date Fair ValueNumber of SharesWeighted Average Grant Date Fair Value
Unvested restricted stock units at January 1796 $57 1,154 $57 934 $54 
Granted466 73 205 56 621 59 
Vested(455)57 (532)55 (351)53 
Forfeited(68)68 (32)58 (50)54 
Unvested restricted stock units at December 31738 $66 796 $57 1,154 $57 
Our long-term stock award activity was as follows, shares in thousands:
Year Ended December 31,
202420232022
 Number of SharesWeighted Average Grant Date Fair ValueNumber of SharesWeighted Average Grant Date Fair ValueNumber of SharesWeighted Average Grant Date Fair Value
Unvested stock award shares at January 179 $36 273 $38 608 $37 
Vested(79)36 (191)40 (324)37 
Forfeited— — (3)36 (11)38 
Unvested stock award shares at December 31— $— 79 $36 273 $38 
Information related to phantom stock awards was as follows, dollars in millions and shares in thousands:
 At December 31,
 20242023
Accrued compensation cost liability$$
Unrecognized compensation cost$$
Equivalent common shares96 126 
Schedule of the Company's Stock Option Activity
Our stock option activity was as follows, shares in thousands:
Year Ended December 31,
202420232022
 Number of SharesWeighted Average Exercise PriceNumber of SharesWeighted Average Exercise PriceNumber of SharesWeighted Average Exercise Price
Outstanding stock options at January 12,254 $45 2,988 $39 2,692 $37 
Granted201 73 228 57 338 59 
Exercised(1,397)41 (940)29 (32)34 
Forfeited(10)57 (22)36 (10)37 
Outstanding stock options at December 311,048 $56 2,254 $45 2,988 $39 
The following table summarizes information for stock options vested and expected to vest and exercisable (vested) stock options, shares in thousands:

Year Ended December 31,
202420232022
 
Vested and Expected to Vest Stock Options
Exercisable (Vested) Stock Options
Vested and Expected to Vest Stock Options
Exercisable (Vested) Stock Options
Vested and Expected to Vest Stock Options
Exercisable (Vested) Stock Options
Number of shares1,0405922,2481,6212,9662,051
Weighted average exercise price$56$49$45$42$39$34
Aggregate intrinsic value$18 million$14 million$48 million$41 million$30 million$28 million
Weighted-average remaining term7 years5 years6 years5 years5 years4 years
Schedule of Weighted Average Grant Date Fair Value of Option Shares Granted and the Assumptions Used to Estimate Those Values Using a Black-Scholes Option Pricing Model
The weighted average grant date fair value of option shares granted and the assumptions used to estimate those values using a Black-Scholes option pricing model were as follows:
Year Ended December 31,
202420232022
Weighted average grant date fair value$23.71 $16.91 $14.66 
Risk-free interest rate4.38 %3.95 %1.90 %
Dividend yield1.59 %2.02 %1.89 %
Volatility factor31.00 %31.00 %29.00 %
Expected option life6 years6 years6 years